Kenvue Inc. (kvue)
KVUE — Company Overview
Kenvue Inc. (KVUE) trades on NYQ as part of the Consumer Defensive peer group (Household & Personal Products).
| Ticker | KVUE |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Exchange | NYQ |
| Market cap | $33.94B |
| Last price | $17.67 |
| Size category | Large Cap |
KVUE — Business Description
KVUE represents a Household & Personal Products business in the Consumer Defensive segment. Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl…
Official website: https://www.kenvue.com.
KVUE — Investment Thesis
At a high level, KVUE offers exposure to Consumer Defensive with metrics outlined below from public market data.
- Revenue is expanding at roughly 3.0% year-over-year (public data).
- Trailing P/E of 21.04× sits in a moderate band relative to high-growth peers.
- Forward P/E (14.25×) is below trailing P/E — earnings may be expected to improve.
- Dividend yield near 4.7% adds an income component to total return.
- Equity market capitalization is approximately $33.94B.
See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.
KVUE — Financial Health
Key financial health indicators for Kenvue Inc. are derived exclusively from public data — no proprietary estimates.
Profit margin near 10.8% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $1.91B supports balance-sheet flexibility.
| Trailing P/E | 21.04× |
| Forward P/E | 14.25× |
| Price / Sales | 2.20× |
| Price / Book | 3.22× |
| Gross margin | 58.4% |
| Operating margin | 19.4% |
| Profit margin | 10.8% |
| Return on equity | 15.6% |
| Debt / Equity | 81.62 |
| Free cash flow | $1.91B |
KVUE — Growth Outlook
Growth outlook for Kenvue Inc. (KVUE) depends on demand trends in Household & Personal Products and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 3.0% suggests steady but measured expansion.
- Earnings growth of 8.5% year-over-year supports improving profitability.
- Price is 12.2% below the 52-week high.
- Shares trade 26.0% above the 52-week low — limited rebound so far.
KVUE — Competitive Position
Kenvue Inc. (KVUE) is evaluated against peers on scale, margin structure, and capital efficiency within Consumer Defensive.
- Competes within Consumer Defensive, specifically in Household & Personal Products.
- Market capitalization of $33.94B places KVUE among large-cap peers.
- Gross margin near 58.4% may reflect pricing power or favorable mix.
KVUE — Strengths
Strengths for Kenvue Inc. (KVUE) inferred from public financial metrics:
- Earnings growth of 8.5% year-over-year.
- Return on equity near 15.6% — efficient use of shareholder capital.
- Gross margin of 58.4% supports competitive unit economics.
- Positive free cash flow ($1.91B).
- Dividend yield of 4.7% for income-oriented holders.
- Large Cap scale ($33.94B) may provide distribution and funding advantages.
KVUE — Weaknesses
Weaknesses and pressure points for Kenvue Inc. (KVUE) based on available data:
Insufficient public data to assess this factor.
KVUE — Opportunities
- Dividend yield of 4.7% appeals to total-return investors.
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
- Forward earnings multiple below trailing P/E — potential earnings acceleration ahead.
KVUE — Risks
- Standard market, regulatory, competitive, and execution risks apply to all public equities.
KVUE — Summary
Kenvue Inc. (KVUE) is a large-cap Consumer Defensive company focused on Household & Personal Products, listed on NYQ. Last price $17.67 with market cap $33.94B. Trailing P/E 21.04×. Revenue grew 3.0% year-over-year per public data. Notable strengths include earnings growth of 8.5% year-over-year. Premium Terminal tools for Kenvue Inc. add ownership analytics, news, and richer estimate history beyond this public summary.
Start Free — open KVUE in Vest Terminal
Access live data, filings, ownership, and analysis for Kenvue Inc..
Kenvue Inc. FAQ
What does Kenvue Inc. (KVUE) do?
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-th…
What is KVUE's P/E ratio?
Kenvue Inc. has a trailing P/E of 21.04× based on publicly available market data.
Does KVUE pay a dividend?
Indicated dividend yield: 4.7%. Confirm ex-dates and payout history in Vest Terminal.
What sector is KVUE in?
Kenvue Inc. is classified in Consumer Defensive (Household & Personal Products) on NYQ.
What is KVUE's market capitalization?
Approximate market cap: $33.94B.
What are the main risks for KVUE?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of KVUE?
Potential positives include earnings growth of 8.5% year-over-year, return on equity near 15.6% — efficient use of shareholder capital.
Where can I get analyst estimates for KVUE?
Public analyst price targets and consensus for Kenvue Inc. are on the free /stocks/kvue/estimates page. Deeper estimate history and models are available in Vest Terminal.